The 2.5 day conference is designed to provide an unparalleled platform for integrating current knowledge on placebo research in pain, alcohol use disorders, and substance use disorders.
Pain and alcohol are inter-related conditions with large and individually variable placebo effects on disease progression and response to treatments.
The ultimate goal of this conference is to develop holistic and adequate strategies for better management and treatment of these conditions.
In response to the ongoing COVID-19 pandemic, recommendations by the CDC Guiding Principles for Events and Gatherings and decision by the University of Maryland, Baltimore to maintain virtual operations through March 2021, this Program will now be held virtually. Innovative technology will provide a rich, interactive learning experience for all attendees.
with live streamed presentations, participate in live Q & A sessions,
special interest chat rooms, and pre-recorded sessions
Jeff Fish, PhD
Placebo Therapy Memories:
Influences on Writing the Book 50 Years Ago
Wayne, B. Jonas, MD
How Placebo Research Informs Healing
George F. Koob, PhD
Negative emotional state neuroadaptations in addiction and how they can become conditioned to cues and context
Howard Fields, MD, PhD
Prediction, Expectation, and Pain Control
Charlotte Blease, PhD
Sharing online clinical notes with patients: Implications for placebo and nocebo effects
David Rakel, MD
The Clinician Effect: You are the Strongest Medicine to Reduce Pain and Suffering
Jens Gaab, Prof. Dr.
Why psychotherapy is an open-label placebo and open-label placebo is psychotherapy